Protein S Deficiency
@proteinsdeficiency.com
Aiming to improve understanding and awareness of Protein S Deficiency
Large-scale data analysis has revealed a stronger correlation between defective PROS1 and venous thrombosis, and many patients with PSD have other factors influencing their Protein S levels. PROS1 is not associated with an increased risk of arterial thrombosis. www.hcplive.com/view/bendapu...
January 3, 2025 at 1:37 PM
Large-scale data analysis has revealed a stronger correlation between defective PROS1 and venous thrombosis, and many patients with PSD have other factors influencing their Protein S levels. PROS1 is not associated with an increased risk of arterial thrombosis. www.hcplive.com/view/bendapu...
Progress for patients with Von Willebrand Disease (VWD) using a monoclonal antibody that targets Protein S www.biospace.com/press-releas... #ProteinS #VWD
Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
www.biospace.com
December 12, 2024 at 12:45 PM
Progress for patients with Von Willebrand Disease (VWD) using a monoclonal antibody that targets Protein S www.biospace.com/press-releas... #ProteinS #VWD
High five to G Rouse (clinical assistant), J Pope (pharmacist), and R G Dalton (1954-2003, consultant haematologist) at Cheltenham General Hospital for their letter to the BMJ in 1996, recommending the introduction of 0.5mg warfarin tablets, and a score line making 0.25mg dosage possible. #warfarin
December 5, 2024 at 6:25 PM
High five to G Rouse (clinical assistant), J Pope (pharmacist), and R G Dalton (1954-2003, consultant haematologist) at Cheltenham General Hospital for their letter to the BMJ in 1996, recommending the introduction of 0.5mg warfarin tablets, and a score line making 0.25mg dosage possible. #warfarin
PSD affects: the pathways of “acute phase response”, “FXR/RXR activation”, “serotonin receptor signaling”, and “p70S6K signaling”, indicating interaction disorders among coagulation, inflammatory immune, and lipid metabolism. (page 4550) pubmed.ncbi.nlm.nih.gov/39265992/ #proteinsdeficiency
Proteome and Metabolome Profiling of Anticoagulant Disorders Induced by Familial Protein S Deficiency - PubMed
Protein S deficiency (PSD) is an autosomal dominant disorder characterized by congenital thrombophilia. Studies on PSD are limited yet, resulting in a lack of clarity about molecular changes during ab...
pubmed.ncbi.nlm.nih.gov
November 21, 2024 at 2:18 PM
PSD affects: the pathways of “acute phase response”, “FXR/RXR activation”, “serotonin receptor signaling”, and “p70S6K signaling”, indicating interaction disorders among coagulation, inflammatory immune, and lipid metabolism. (page 4550) pubmed.ncbi.nlm.nih.gov/39265992/ #proteinsdeficiency
Protein S Deficiency (PSD) is a rare blood disorder that affects just a few thousand people worldwide. It is one of several known risk factors for thrombophilia and can increase the risk of blood clots such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). #proteinsdeficiency #thrombosis
November 21, 2024 at 1:06 PM
Protein S Deficiency (PSD) is a rare blood disorder that affects just a few thousand people worldwide. It is one of several known risk factors for thrombophilia and can increase the risk of blood clots such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). #proteinsdeficiency #thrombosis